Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

OriGene Pays $6.5 Million for Shenzhen P&A Biotech

publication date: Feb 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

OriGene Technologies Inc of Rockville, MD purchased the assets of Shenzhen P&A Biotech, a privately owned company that provides monoclonal antibodies to the research industry. OriGene will use the assets to establish a high throughput monoclonal antibody production outsourcing center in China. The company raised $6.5 million in private equity to finance the purchase. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...